ICER Mixes Up Priorities in Asthma Drug Review
October 15, 2021
ICER’s priorities differ from severe asthma patients’, and the economists’ approach could make it harder for patients to access the treatment they need.
Tags: ICER, RespiratoryCategorized in: Analysis